
In the US, it looks like a new major lawsuit will revolve around Leo Pharma's drug Picato, according to Bloomberg Law.
In the State of New York, a motion has been made for a class-action lawsuit in which one person or minor group represents a large number of people seeking to be compensated.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app